Oral Proteins and Peptides Market Research Report 2022-2028 | Share, Global Trends, Key Players, Growth Analysis

The Oral Proteins and Peptides Market size is expected to grow at an annual average of 10% during 2021-2027. Protein and peptide-based therapeutics have been in use for more than 30 years since the first protein therapy, recombinant human insulin, was approved in 1982. Previously, most biological drugs were delivered via the subcutaneous route. However, over time, advances in delivery formulations have made it possible to develop orally administered versions of therapeutic proteins/peptides. For a number of compelling reasons, the concept of oral delivery has gained considerable traction.

The following segmentation are covered in this report:

By Application

• Gastric & Digestive Disorders
• Bone Diseases
• Diabetes
• Hormonal Disorders

By Drug Type

• Linaclotide
• Plecanatide
• Calcitonin
• Insulin
• Octreotide

Company Profile

• Allergan plc
• AstraZeneca plc
• Biocon Limited
• Chiasma, Inc.
• Proxima Concepts Limited (Diabetology Ltd.)
• Generex Biotechnology Corp.
• Novo Nordisk A/S
• Synergy Pharmaceuticals Inc.
• Tarsa Therapeutics Inc.

Scope of the report

The research study analyses the Oral Proteins and Peptides Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Oral Proteins and Peptides Market Report

• What was the Oral Proteins And Peptides Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Oral Proteins And Peptides Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.